Two for Two on The Analytical Scientist's Power List
Two from ASTech (Trajan's collaboration with UTAS and ARC) have graced The Analytical Scientist's Power Lists for two consecutive years:
- 2013 and 2014 - Emily Hilder, ASTech Training Centre Director; Professor and Head of Discipline, Chemistry, Australian Centre for Research on Separation Science (ACROSS), School of Physical Sciences, UTAS.
- 2014 - Michael Breadmore, ASTech Steering Committee Member; Professor and ARC Future Fellow, Australian Centre for Research on Separation Science (ACROSS), School of Physical Science, UTAS.
This could be you! Boost your postgraduate career at ASTech. Apply now.
Read more at The Analytical Scientist:
- The Power List 2014 - Top 40 under 40
- The Power List 2013 - Top 100 most influential analytical scientists
 have graced The Analytical Scientist's Power Lists for two consecutive years:
2013 and 2014 - Emily Hilder, ASTech Training Centre Director; Professor and Head of Discipline, ...&media=//cdn.shopify.com/s/files/1/0767/9441/articles/Parc_02_HR_aa439861-adc9-4415-87bb-69906986939a_600x.jpg?v=1452494990){kind=link}
Also in News
Interview: Why data quality plays a critical role in personalized medicine, with microsampling expert Dr Michele Protti
Trajan Scientific and Medical’s hemaPEN® microsampling technology has been developed with extensive consultation and evaluation by leading analytical laboratories, clinicians and healthcare professionals.
This month, Trajan presents an exclusive interview with researcher Dr Michele Protti of Pharmaco-Toxicological Analysis, Bologna, Italy, on the future of microsampling and the critical role hemaPEN can play when used in therapeutic drug monitoring for optimal therapy personalization.
Trajan celebrates International Pathology Day with ScyTek Laboratories to deliver quality IHC solutions
Advantages of hemaPEN blood microsampling validated for therapeutic drug monitoring in RSC’s Analyst
Trajan Scientific and Medical’s hemaPEN® has been independently evaluated and the results of the study published in the Royal Society of Chemistry’s journal Analyst - selected for the cover of issue 17. hemaPEN demonstrated significant advantages for blood sampling to support better healthcare decision making.